• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 15-11-2025: Press Release

    15-11-2025 | 09:10 am

    Alembic Pharmaceuticals received USFDA final approval for Diltiazem Hydrochloride tablets (30-120 mg) to treat angina. This enhances their US product portfolio, paving the way for new market opportunities and potential revenue expansion.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited